rs3745601

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_002566.5(P2RY11):​c.259G>A​(p.Ala87Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.128 in 1,609,842 control chromosomes in the GnomAD database, including 15,102 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: 𝑓 0.13 ( 1578 hom., cov: 34)
Exomes 𝑓: 0.13 ( 13524 hom. )

Consequence

P2RY11
NM_002566.5 missense

Scores

3
14

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: 1.19

Publications

47 publications found
Variant links:
Genes affected
P2RY11 (HGNC:8540): (purinergic receptor P2Y11) The product of this gene belongs to the family of G-protein coupled receptors. This family has several receptor subtypes with different pharmacological selectivity, which overlaps in some cases, for various adenosine and uridine nucleotides. This receptor is coupled to the stimulation of the phosphoinositide and adenylyl cyclase pathways and behaves as a selective purinoceptor. Naturally occuring read-through transcripts, resulting from intergenic splicing between this gene and an immediately upstream gene (PPAN, encoding peter pan homolog), have been found. The PPAN-P2RY11 read-through mRNA is ubiquitously expressed and encodes a fusion protein that shares identity with each individual gene product. [provided by RefSeq, Jul 2008]
PPAN-P2RY11 (HGNC:33526): (PPAN-P2RY11 readthrough) This locus represents naturally occurring read-through transcription between the adjacent PPAN and P2RY11 genes. Alternative splicing results in two transcript variants, one of which encodes a fusion protein that shares sequence identity with each individual gene product. This transcript is found to be ubiquitously expressed and is up-regulated by agents inducing granulocytic differentiation. However, its functional significance in vivo remains unclear. [provided by RefSeq, Nov 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012397438).
BP6
Variant 19-10113872-G-A is Benign according to our data. Variant chr19-10113872-G-A is described in ClinVar as Benign. ClinVar VariationId is 3059970.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.347 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
P2RY11NM_002566.5 linkc.259G>A p.Ala87Thr missense_variant Exon 2 of 2 ENST00000321826.5 NP_002557.2 Q96G91
PPAN-P2RY11NM_001040664.3 linkc.1519G>A p.Ala507Thr missense_variant Exon 13 of 13 NP_001035754.1 Q9NQ55A0A0B4J1V8
PPAN-P2RY11NM_001198690.2 linkc.*18G>A 3_prime_UTR_variant Exon 13 of 13 NP_001185619.1 A0A0A6YYI3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
P2RY11ENST00000321826.5 linkc.259G>A p.Ala87Thr missense_variant Exon 2 of 2 1 NM_002566.5 ENSP00000323872.4 Q96G91
PPAN-P2RY11ENST00000393796.4 linkc.1519G>A p.Ala507Thr missense_variant Exon 13 of 13 1 ENSP00000377385.4 A0A0B4J1V8
PPAN-P2RY11ENST00000428358.5 linkc.*18G>A 3_prime_UTR_variant Exon 13 of 13 2 ENSP00000411918.1 A0A0A6YYI3
P2RY11ENST00000471843.1 linkn.*38G>A downstream_gene_variant 4

Frequencies

GnomAD3 genomes
AF:
0.131
AC:
19950
AN:
152076
Hom.:
1573
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.106
Gnomad AMI
AF:
0.136
Gnomad AMR
AF:
0.149
Gnomad ASJ
AF:
0.116
Gnomad EAS
AF:
0.361
Gnomad SAS
AF:
0.206
Gnomad FIN
AF:
0.149
Gnomad MID
AF:
0.142
Gnomad NFE
AF:
0.118
Gnomad OTH
AF:
0.125
GnomAD2 exomes
AF:
0.162
AC:
39430
AN:
243908
AF XY:
0.160
show subpopulations
Gnomad AFR exome
AF:
0.110
Gnomad AMR exome
AF:
0.190
Gnomad ASJ exome
AF:
0.122
Gnomad EAS exome
AF:
0.396
Gnomad FIN exome
AF:
0.152
Gnomad NFE exome
AF:
0.116
Gnomad OTH exome
AF:
0.147
GnomAD4 exome
AF:
0.127
AC:
185843
AN:
1457646
Hom.:
13524
Cov.:
37
AF XY:
0.129
AC XY:
93903
AN XY:
725138
show subpopulations
African (AFR)
AF:
0.105
AC:
3509
AN:
33466
American (AMR)
AF:
0.189
AC:
8430
AN:
44600
Ashkenazi Jewish (ASJ)
AF:
0.120
AC:
3133
AN:
26084
East Asian (EAS)
AF:
0.315
AC:
12471
AN:
39642
South Asian (SAS)
AF:
0.199
AC:
17131
AN:
86208
European-Finnish (FIN)
AF:
0.149
AC:
7545
AN:
50528
Middle Eastern (MID)
AF:
0.110
AC:
637
AN:
5766
European-Non Finnish (NFE)
AF:
0.112
AC:
124768
AN:
1111060
Other (OTH)
AF:
0.136
AC:
8219
AN:
60292
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
11517
23034
34550
46067
57584
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4690
9380
14070
18760
23450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.131
AC:
19974
AN:
152196
Hom.:
1578
Cov.:
34
AF XY:
0.137
AC XY:
10179
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.106
AC:
4381
AN:
41524
American (AMR)
AF:
0.149
AC:
2278
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.116
AC:
404
AN:
3470
East Asian (EAS)
AF:
0.361
AC:
1862
AN:
5162
South Asian (SAS)
AF:
0.207
AC:
997
AN:
4828
European-Finnish (FIN)
AF:
0.149
AC:
1577
AN:
10602
Middle Eastern (MID)
AF:
0.139
AC:
41
AN:
294
European-Non Finnish (NFE)
AF:
0.118
AC:
8044
AN:
68000
Other (OTH)
AF:
0.126
AC:
266
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
906
1811
2717
3622
4528
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
232
464
696
928
1160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.126
Hom.:
3709
Bravo
AF:
0.132
TwinsUK
AF:
0.109
AC:
404
ALSPAC
AF:
0.106
AC:
408
ESP6500AA
AF:
0.109
AC:
479
ESP6500EA
AF:
0.114
AC:
978
ExAC
AF:
0.157
AC:
19036
Asia WGS
AF:
0.258
AC:
894
AN:
3478
EpiCase
AF:
0.115
EpiControl
AF:
0.115

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

P2RY11-related disorder Benign:1
Oct 21, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.043
.;T
Eigen
Benign
0.025
Eigen_PC
Benign
-0.061
FATHMM_MKL
Benign
0.23
N
LIST_S2
Benign
0.76
T;T
MetaRNN
Benign
0.012
T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Uncertain
2.1
.;M
PhyloP100
1.2
PROVEAN
Benign
-0.46
N;N
REVEL
Benign
0.083
Sift
Uncertain
0.0050
D;T
Sift4G
Benign
0.14
T;T
Polyphen
0.99
.;D
Vest4
0.14
MPC
0.35
ClinPred
0.023
T
GERP RS
3.5
Varity_R
0.10
gMVP
0.24
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3745601; hg19: chr19-10224548; COSMIC: COSV53450975; COSMIC: COSV53450975; API